To tap or not to tap: Cerebrospinal fluid biomarkers of Alzheimer's disease

被引:7
作者
Growdon, JH [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
关键词
D O I
10.1002/ana.410440105
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:6 / 7
页数:2
相关论文
共 10 条
[1]  
Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109
[2]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[3]   NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE [J].
ARRIAGADA, PV ;
GROWDON, JH ;
HEDLEYWHYTE, ET ;
HYMAN, BT .
NEUROLOGY, 1992, 42 (03) :631-639
[4]   Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease [J].
Galasko, D ;
Clark, C ;
Chang, L ;
Miller, B ;
Green, RC ;
Motter, R ;
Seubert, P .
NEUROLOGY, 1997, 48 (03) :632-635
[5]  
GomezIsla T, 1996, J NEUROSCI, V16, P4491
[6]   INCREASED LEVELS OF TAU-PROTEIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE - CORRELATION WITH DEGREE OF COGNITIVE IMPAIRMENT [J].
HOCK, C ;
GOLOMBOWSKI, S ;
NASER, W ;
MULLERSPAHN, F .
ANNALS OF NEUROLOGY, 1995, 37 (03) :414-415
[7]   Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease:: A study in Japan [J].
Kanai, M ;
Matsubara, E ;
Isoe, K ;
Urakami, K ;
Nakashima, K ;
Arai, H ;
Sasaki, H ;
Abe, K ;
Iwatsubo, T ;
Kosaka, T ;
Watanabe, M ;
Tomidokoro, Y ;
Shizuka, M ;
Mizushima, K ;
Nakamura, T ;
Igeta, Y ;
Ikeda, Y ;
Amari, M ;
Kawarabayashi, T ;
Ishiguro, K ;
Harigaya, Y ;
Wakabayashi, K ;
Okamoto, K ;
Hirai, S ;
Shoji, M .
ANNALS OF NEUROLOGY, 1998, 44 (01) :17-26
[8]   Evaluation and use of diagnostic tests in Alzheimer's disease [J].
Mayeux, R .
NEUROBIOLOGY OF AGING, 1998, 19 (02) :139-143
[9]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[10]   REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE [J].
MOTTER, R ;
VIGOPELFREY, C ;
KHOLODENKO, D ;
BARBOUR, R ;
JOHNSONWOOD, K ;
GALASKO, D ;
CHANG, L ;
MILLER, B ;
CLARK, C ;
GREEN, R ;
OLSON, D ;
SOUTHWICK, P ;
WOLFERT, R ;
MUNROE, B ;
LIEBERBURG, I ;
SEUBERT, P ;
SCHENK, D .
ANNALS OF NEUROLOGY, 1995, 38 (04) :643-648